Related Experiment Video
Updated: May 23, 2025

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
PSPC1 bridges cancer stemness and malignancy in acute myeloid leukemia
Hsi-Wen Yeh1, Yaw-Dong Lang2, Hsin-Yi Lee1
1Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.
Abstract:
In a recent publication in Cell Stem Cell, Hong et al.1 uncovered paraspeckle component 1 (PSPC1) as a determinant of leukemogenic characteristics in acute myeloid leukemia (AML). PSPC1 is not essential for normal hematopoiesis but it is upregulated to interact with PU.1 to promote AML progression and is also emerging as a therapeutic target.
Related Concept Videos
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Abnormal Proliferation
Lineage Commitment
Induced Pluripotent Stem Cells
Somatic...
Multipotency of Hematopoietic Stem Cells
Differentiation of Common Myeloid Progenitor Cells

